IRIS
BERTINO, Gaetano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.730
EU - Europa 3.035
AS - Asia 1.415
AF - Africa 355
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
SA - Sud America 3
Totale 9.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.460
IE - Irlanda 869
UA - Ucraina 773
CN - Cina 746
IT - Italia 741
SG - Singapore 560
CI - Costa d'Avorio 267
CA - Canada 262
RU - Federazione Russa 217
SE - Svezia 104
DE - Germania 88
SN - Senegal 77
GB - Regno Unito 57
VN - Vietnam 41
FR - Francia 40
BE - Belgio 26
AT - Austria 21
IN - India 20
CZ - Repubblica Ceca 19
CH - Svizzera 18
NL - Olanda 17
GR - Grecia 14
UZ - Uzbekistan 14
EU - Europa 10
NG - Nigeria 10
IR - Iran 9
PL - Polonia 9
FI - Finlandia 6
LB - Libano 6
MX - Messico 6
QA - Qatar 6
BG - Bulgaria 5
AU - Australia 4
HK - Hong Kong 4
HR - Croazia 3
RO - Romania 3
TR - Turchia 3
JP - Giappone 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
BA - Bosnia-Erzegovina 1
BR - Brasile 1
CR - Costa Rica 1
ES - Italia 1
GH - Ghana 1
IM - Isola di Man 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PA - Panama 1
SA - Arabia Saudita 1
Totale 9.553
Salva come PNG Salva come JPEG
Città #
Dublin 865
Chandler 753
Jacksonville 690
Chicago 394
Singapore 380
Boardman 350
Abidjan 267
Nanjing 247
Lawrence 242
Andover 240
Cambridge 240
Toronto 214
Catania 152
Houston 137
Des Moines 126
Ashburn 118
Wilmington 99
San Mateo 98
Dakar 77
Shenyang 75
Nanchang 69
Saint Petersburg 66
Hebei 54
Changsha 48
Bremen 46
Ottawa 46
Jiaxing 42
Milan 42
Mountain View 41
Tianjin 41
Los Angeles 32
Dong Ket 29
Santa Clara 29
Beijing 27
Palermo 27
Brussels 26
Moscow 24
Norwalk 16
Rome 16
Falls Church 15
Redmond 14
Brno 12
Foggia 12
Hanoi 12
Jinan 12
Leawood 12
Mascalucia 12
Pune 12
Kunming 11
Seattle 11
Washington 11
Abuja 10
Den Haag 10
Liberty Lake 10
Modica 10
London 8
Naples 8
Florence 7
Frankfurt Am Main 7
Ningbo 7
Siracusa 7
Ardabil 6
Bari 6
Carlentini 6
Hangzhou 6
Kiev 6
Trecastagni 6
Turin 6
Zhengzhou 6
Ann Arbor 5
Augusta 5
Changchun 5
Ciudad Obregón 5
Dearborn 5
Lausanne 5
Rosolini 5
Villamagna 5
Belpasso 4
Edinburgh 4
Fontaniva 4
Grafing 4
Guangzhou 4
Helsinki 4
Hong Kong 4
Livorno 4
Lyon 4
Messina 4
Milazzo 4
Santa Venerina 4
Trieste 4
Aachen 3
Amsterdam 3
Brescia 3
Civitavecchia 3
Esslingen am Neckar 3
Favara 3
Gorla Minore 3
Hanover 3
Munich 3
Pesaro 3
Totale 6.885
Salva come PNG Salva come JPEG
Nome #
Commentary on "Insertion of Totally Implantable Central Venous Access Devices by Surgeons" - What Is the Role of Surgeons When Implanting a Totally Implantable Venous Access Device to Prevent Immediate Complications? 126
Carbohydrate 19.9 Antigen Serum Levels in Liver Disease 110
Eterozigosi H36D per Emocromatosi in pazienti affetti da Steatoepatite e Epatite cronica da virus C 94
Type II Mixed Cryoglobulinemia In Patients With Hepatitis C Virus: Treatment with Pegylated-Interferon and Ribavirin 87
Possibile associazione di anemia normocromica con maggiore incremento delle molecole di adesione ICAM-2 e VCAM-1 in pazienti con cirrosi epatica: studio pilota 79
Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer 79
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 78
Anorectal mucosal melanoma 77
Carotid Intima-Media Thickness and Liver Histology in Hemodialysis Patients with Non-Alcoholic Fatty Liver Disease 74
Eritropoietina nel trattamento dell'anemia secondaria a terapia con interferone peghilato e ribavirina 73
Obesity and related diseases: an epidemiologic study in Eastern Sicily 72
Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives 72
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 72
Epatite cronica: un caso di sovrapposizione epatite autoimmune-epatite virale 71
Trattamento con peg-interferone e ribavirina nell’epatite cronica attiva C ed insorgenza di malattia celiaca: esiste una relazione ? 68
A study about mechanism of des-gamma-carboxy prothrombin’s production in hepatocellular carcinoma 67
Laparoscopic Reversal of Hartmann's Procedure: State of the Art 20 Years after the First Reported Case 66
Trattamento dell'epatite cronica B, HBeAg negativa, con terapia di combinazione: Adefovir e Interferone-Pegilato alfa 2a vs Adefovir (Studio PAC: Peg Adefovir Combination) 66
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 65
Hepatocellular carcinoma serum markers 65
D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis 65
Immune response in addicts with chronic hepatitis C treated with interferon and ribavirine 64
High carbohydrate 19-9 antigen serum levels in patients with nonmelanoma skin cancer and primary occult cancer 64
Meaning of elevated CA 19-9 serum levels in chronic hepatitis and HCV-related cirrhosis 63
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study 61
Riduzione della densità minerale ossea volumetrica (pQCT) in pazienti con epatopatia cronica HCV-correlata: confronto con la misurazione DEXA 61
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 61
Folate levels in hepatocellular carcinoma patients with portal vein thrombosis 61
Homocysteine serum levels as prognostic marker of hepatocellular carcinoma with portal vein thrombosis 60
Evaluation of health status in patients with hepatitis c treated with and without interferon 59
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 59
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance 59
Resveratrol in Patients with Minimal Hepatic Encephalopathy 59
Assessing degree of hepatic fibrosis in patients with chronic liver disease using gadoxetic acid-enhanced liver MRI: Preliminary results 59
Circulating adhesion molecules in patients with virus-related chronic diseases of the liver 58
Persistent increase in alpha-fetoprotein level in a patient without underlying liver disease who underwent curative resection of hepatocellular carcinoma. A case report and review of the literature 58
Systemic Therapies in Hepatocellular carcinoma: present and future 55
Totally Implantable Venous Access Devices: Efforts Are Needed to Standardize Procedures to Avoid Complications 55
Endozepine-4 levels are increased in hepatic coma. 55
Incidence and causes of neonatal hyperbilirubinemia in a center of Catania 54
ON-TREATMENT HBsAg DECLINE IS ASSOCIATED WITH SUBSEQUENT HBsAg REDUCTION IN HBeAg NEGATIVE CHRONIC HEPATITIS B 54
Association Between Diabetes Mellitus, Hepatic Steatosis And Fibrosis In Chronic Hepatitis C Patients 54
A phase IIIb, 2X2 factorial, double blind study of 48 versus 96 weeks of peg-Interferon alpha 2a 180 micrg, with or without 24 weeks of Entecavir in adult patients with HbeAg negative chronic hepatitis B 54
Blood homocysteine levels are increased in hepatocellular carcinoma patients with portal vein thrombosis. A single centre retrospective cohort study 54
Priority of the chronic HBV pathology in a samples of subjects suffering from liver disorder and hospitalized in the last triennium 53
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. 53
Chronic hepatitis C: This and the new era of treatment 53
Giant cavernous liver hemangiomas: is it the time to change the size categories? 53
Circulating erytropoietin in microalbuminuric type 2 diabetic patients with normal renal function: a pilot study 52
Experience with vaccination against hepatitis B 51
AIDS. Sindrome da Immunodeficienza Acquisita 51
Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study 51
Potential role of probiotics on colorectal cancer prevention 51
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients. 51
Chronic anaemia and adhesion molecules in patients with liver cirrhosis. A preliminary report 50
Vaccinazione anti-epatite B: differenze della risposta immune con Hevac B Pasteur in rapporto all'età 50
Rare benign tumors of the liver: still rare? 50
Silybin supplementation during HCV therapy with pegylated interferon-a plus ribavirin reduces depression and anxiety and increases work ability 50
Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase -2 in patients with HCV-related chronic hepatitis. Relationship to histological features 50
Reduction of volumetric bone mineral density in postmenopausal women with HCV-correlated chronic liver disease: a peripheral quantitative computed tomogtraphy (pQCT) study 50
A therapeutic education and medical support program improves adherence to therapy with peg-interferon plus ribavirin therapy and increases sustained virological response in patients with chronic hepatitis C 50
Polyunsaturated phosphatidylcholine (EPL) in the management of liver steatosis 49
Liver immunolocalization and plasma levels of MMP-9 in non-alcoholic steatohepatitis (NASH) and hepatitis C infection 49
What are the true advantages of devices for hepatic parenchimal transection in open surgery? 49
Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic epatiti C treated with pegylated interferon α and ribavirin 49
INFEZIONE DA HAV IN PAZIENTI CON EPATITE CRONICA HCV-CORRELATA 49
POST-LOAD INSULIN RESISTANCE IS AN INDEPENDENT PREDICTOR OF HEPATIC FIBROSIS IN DIABETIC PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE 49
Some patients with HCC havent't abnormal des-gamma-carboxy prothrombin and alpha-fetoprotein levels 49
Carnitine Serum Levels in Frail Older Subjects 49
Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis 49
The HCV Sicily Network: a web-based model for the management of HCV chronic liver diseases 48
Behavior of alpha-1-antitrypsin in adults with chronic liver disease 48
Biochemical long-term outcomes in chronic hepatitis C patients treated with a twelve months course of alpha lymphoblastoid interferon 48
Eritropoietina nel trattamento dell’anemia secondaria a terapia con interferone peghilato e ribavirina 48
Current practice of chronic hepatitis B treatment in Southern Italy 48
Genotype-phenotype variable correlation in Wilson disease: clinical history of two sisters with the similar genotype 48
An unusual case of HBV reactivation in a patient with cholangitis and choledocho-lithiasis undergone to ERCP. A case report 48
La metalloproteinasi-2 è un marker indiretto di citonecrosi e fibrosi epatica nell’epatite cronica HCV-correlata 47
A case of Overlap Syndrome:Autoimmune idiopatic hepatitis/pulmonary idiopatic hypertension 47
Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis 47
Iron depletion and lifestyle modifications improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia 46
Studio trasversale sul portatore cronico di HBsAg 46
Carbohydrate 19-9 antigen in chronic viral hepatitis without neoplasia is associated with the severity of liver disease 46
Hepatocellular carcinoma and the risk of occupational exposure. 46
Combined duodenal and pancreatic major trauma in high risk patients: can a partial reconstruction be safe? 46
Hepatocellular Carcinoma 46
Respiratory and Cardiovascular Health Effects of e-Cigarette Substitution: Protocol for Two Living Systematic Reviews 46
Emerging hepatic syndromes: pathophysiology, diagnosis and treatment 45
Plasma erythropoietin levels in anaemic and non-anaemic patients with chronic liver diseases 45
Does follow-up offer the best quality of life for patients affected by so-called 'giant' haemangiomas of the liver? 45
Hepatocellular Carcinoma: present and future 45
Incidence of Hepatocellular Carcinoma in Patients with HCV-associated Cirrhosis Treated with Direct-Acting Antiviral Agents 45
Acetyl-L-carnitine can slow the progression from prefrailty to frailty in older subjects. A randomized interventional clinical trial 44
Prognostic and diagnostic value of des-gamma-carboxyprothrombin in liver cancer 44
ON-TREATMENT SERUM HBsAG DECLINE DURING TELBIVUDINE THERAPY IN NAÏVE CHRONIC HEPATITIS B: CASE REPORT 44
Plasma ICAM-1 and VCAM-1 levels in type 2 diabetic patients with and without microalbuminuria 44
Greater severity of new onset asthma in allergic subjects who smoke: a 10-year longitudinal study 44
Pegylated-interferon and ribavirin therapy of HCV-related type II mixed cryoglobulinemia 44
A Multidisciplinary Therapeutic Approach for Reducing the Risk of Psychiatric Side Effects in Patients With Chronic Hepatitis C Treated With Pegylated Interferon α and Ribavirin 44
SAFETY AND EFFICACY OF LOW DOSAGE OF FONDAPARINUX IN CIRRHOTIC PATIENTS WITH PORTAL VEIN THROMBOSIS 44
Totale 5.653
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020712 0 0 101 42 77 18 101 21 149 28 110 65
2020/20211.374 19 114 169 40 377 49 159 18 102 60 187 80
2021/20221.744 223 281 20 27 270 14 256 55 137 6 62 393
2022/20232.628 258 99 40 231 242 445 17 452 678 25 81 60
2023/20241.228 69 163 45 57 50 266 24 91 13 41 231 178
2024/20251.119 79 759 281 0 0 0 0 0 0 0 0 0
Totale 10.153